Cboe BZX Exchange approved the listing of the 21Shares Core XRP Trust Wednesday, clearing the final exchange-level hurdle for the fifth U.S. spot XRP product. The fund will trade under the ticker TOXR.
XRP traded at $2.01 (-3%) following the disclosure, consolidating after a 7% weekly drawback.
The Details: Aggressive Seeding & Custody Split
The 21Shares filing reveals a distinct capital structure designed to force immediate liquidity:
- The Seed: Ripple Markets injected 100 million XRP (approx. $226 million) to seed the fund. For context, typical ETF seeds range from $100,000 to $10 million.
- The Fee: 0.30% sponsor fee. This undercuts Grayscale but trails Franklin Templeton’s 0.19%.
- The Custody: Unlike early Bitcoin ETFs that relied heavily on Coinbase, TOXR utilizes a tri-party model with Coinbase Custody, Anchorage Digital, and BitGo.
Market Context
The approval comes as the U.S. spot XRP ETF sector nears $1 billion in AUM less than a month post-launch.
Competitors Bitwise, Canary Capital, and Franklin Templeton have already captured early inflows. 21Shares is betting on the massive seed capital to narrow the gap.
The Institutional Take
Ignore the headline approval; focus on the $226M seed. Ripple is not waiting for organic growth; it is effectively subsidizing the product’s liquidity to ensure tight spreads on Day 1. Furthermore, the inclusion of Anchorage and BitGo for custody is a critical de-risking evolution. Institutional allocators have been wary of “Coinbase concentration risk” (where one entity holds 90% of ETF assets); TOXR’s diversified storage model directly addresses that compliance friction.
